Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erector Spinae Plane Block Vs. IPACK Block with Adductor Canal Block for Total Knee Arthroplasty
NCT06233630Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Mar 2024
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in pain (3 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Opioid consumption at 48 hours. Started Mar 2024; status: completed.
02
Drugs
ropivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06233630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06233630.